Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Idexx Laboratories (IDXX)

Idexx Laboratories (IDXX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 40,210,136
  • Shares Outstanding, K 82,817
  • Annual Sales, $ 3,215 M
  • Annual Income, $ 744,850 K
  • 60-Month Beta 1.17
  • Price/Sales 12.20
  • Price/Cash Flow 48.16
  • Price/Book 83.93
Trade IDXX with:

Options Overview Details

View History
  • Implied Volatility 32.28% ( -2.07%)
  • Historical Volatility 36.62%
  • IV Percentile 1%
  • IV Rank 2.30%
  • IV High 55.98% on 05/11/22
  • IV Low 31.73% on 02/09/22
  • Put/Call Vol Ratio 0.24
  • Today's Volume 428
  • Volume Avg (30-Day) 552
  • Put/Call OI Ratio 0.83
  • Today's Open Interest 11,059
  • Open Int (30-Day) 10,137

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/23
See More
  • Average Estimate 2.38
  • Number of Estimates 6
  • High Estimate 2.51
  • Low Estimate 2.31
  • Prior Year 2.27
  • Growth Rate Est. (year over year) +4.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
442.80 +14.65%
on 01/10/23
510.40 -0.53%
on 02/07/23
+59.91 (+13.38%)
since 01/06/23
3-Month
375.44 +35.22%
on 11/09/22
510.40 -0.53%
on 02/07/23
+122.48 (+31.80%)
since 11/07/22
52-Week
317.06 +60.12%
on 10/13/22
560.92 -9.49%
on 03/29/22
-10.08 (-1.95%)
since 02/07/22

Most Recent Stories

More News
Is AEterna Zentaris (AEZS) Stock Outpacing Its Medical Peers This Year?

Here is how Aeterna Zentaris (AEZS) and Idexx Laboratories (IDXX) have performed compared to their sector so far this year.

AEZS : 3.75 (+0.27%)
IDXX : 507.68 (+4.56%)
Stocks Lower on the Outlook for Hawkish Fed

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.86%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.57%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.10%....

$SPX : 4,164.00 (+1.29%)
SPY : 415.19 (+1.31%)
$DOWI : 34,156.69 (+0.78%)
DIA : 341.52 (+0.90%)
$IUXX : 12,728.27 (+2.12%)
QQQ : 309.88 (+2.07%)
TSN : 61.41 (+0.54%)
PYPL : 83.23 (+1.09%)
PDD : 94.45 (+0.68%)
BABA : 105.50 (+0.05%)
JD : 57.09 (+0.63%)
BIDU : 160.22 (+12.18%)
IDEXX (IDXX) Q4 Earnings Beat Estimates, Margins Increases

IDEXX's (IDXX) Q4 revenues are driven by continued benefits from expanding the global premium instrument installed base.

MCK : 363.61 (+1.53%)
HOLX : 86.16 (+2.16%)
IDXX : 507.68 (+4.56%)
NEOG : 20.39 (+2.51%)
DexCom (DXCM) to Report Q4 Earnings: What's in the Cards?

DexCom's (DXCM) fourth-quarter results are likely to reflect rising global awareness of its real-time CGM.

HOLX : 86.16 (+2.16%)
DXCM : 109.50 (+2.60%)
IDXX : 507.68 (+4.56%)
SWAV : 188.99 (+3.82%)
Idexx Laboratories (IDXX) Q4 Earnings and Revenues Beat Estimates

Idexx (IDXX) delivered earnings and revenue surprises of 6.77% and 1.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

IDXX : 507.68 (+4.56%)
SRTS : 9.06 (+2.72%)
Idexx: Q4 Earnings Snapshot

Idexx: Q4 Earnings Snapshot

IDXX : 507.68 (+4.56%)
IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results

Achieves fourth quarter revenue growth of 3% reported and 7% organic, driven by CAG Diagnostics recurring revenue growth of 4% reported and 8% organic Solid...

IDXX : 507.68 (+4.56%)
Catalent (CTLT) to Report Q2 Earnings: What's in the Cards?

Catalent's (CTLT) Q2 results are likely to have been driven by robust segmental performances.

HAE : 82.57 (-5.91%)
IDXX : 507.68 (+4.56%)
PEN : 267.10 (+2.85%)
CTLT : 71.58 (+6.84%)
Here's How Much a $1000 Investment in Idexx Laboratories Made 10 Years Ago Would Be Worth Today

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

IDXX : 507.68 (+4.56%)
Earnings Preview: Sensus Healthcare, Inc. (SRTS) Q4 Earnings Expected to Decline

Sensus Healthcare, Inc. (SRTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SRTS : 9.06 (+2.72%)
IDXX : 507.68 (+4.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

IDEXX Laboratories, Inc. is a developer, manufacturer and distributer of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care...

See More

Key Turning Points

3rd Resistance Point 546.93
2nd Resistance Point 528.67
1st Resistance Point 518.17
Last Price 507.68
1st Support Level 489.41
2nd Support Level 471.15
3rd Support Level 460.65

See More

52-Week High 560.92
Last Price 507.68
Fibonacci 61.8% 467.77
Fibonacci 50% 438.99
Fibonacci 38.2% 410.21
52-Week Low 317.06

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar